{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:55:48Z","timestamp":1773662148102,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10517-020-05020-3","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T06:02:25Z","timestamp":1606197745000},"page":"142-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of the Chemosensitivity of Uveal Melanoma Cells Ex Vivo"],"prefix":"10.1007","volume":"170","author":[{"given":"S. V.","family":"Saakyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0410. Yu.","family":"Tsygankov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. I.","family":"Moiseeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0410. F.","family":"Karamysheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. D.","family":"Garri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"issue":"4","key":"5020_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.18786\/2072-0505-2017-45-4-321-325","volume":"45","author":"EE Grishina","year":"2017","unstructured":"Grishina EE, Lerner MYu, Gemdzhian EG. Epidemiology of uveal melanomas in Moscow. Al\u2019manakh Klin. Med. 2017;45(4):321-325. Russian.","journal-title":"Al\u2019manakh Klin. Med."},{"key":"5020_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.18869\/acadpub.rmm.2.2.34","volume":"2","author":"SV Saakyan","year":"2014","unstructured":"Saakyan SV, Amiryan AG, Tsygankov AYu, Loginov VI, Burdennyy AM. Mutations in oncogenes GNAQ and GNA11 in uveal melanoma patients. Mol. Med. 2014;(2):34-37. Russian.","journal-title":"Mol. Med."},{"issue":"6","key":"5020_CR3","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/med.21460","volume":"37","author":"B \u00c1lvarez-Rodr\u00edguez","year":"2017","unstructured":"\u00c1lvarez-Rodr\u00edguez B, Latorre A, Posch C, Somoza \u00c1. Recent advances in uveal melanoma treatment. Med. Res. Rev. 2017;37(6):1350-1372.","journal-title":"Med. Res. Rev."},{"issue":"3","key":"5020_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000370150","volume":"1","author":"M Angi","year":"2015","unstructured":"Angi M, Versluis M, Kalirai H. Culturing uveal melanoma cells. Ocul. Oncol. Pathol. 2015;1(3):126-132.","journal-title":"Ocul. Oncol. Pathol."},{"issue":"4","key":"5020_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00280-007-0655-9","volume":"62","author":"J Atzpodien","year":"2008","unstructured":"Atzpodien J, Terfloth K, Fluck M, Reitz M. Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients. Cancer Chemother. Pharmacol. 2008;62(4):685-688.","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"5020_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1046\/j.1365-2230.2000.00690.x","volume":"25","author":"JC Becker","year":"2000","unstructured":"Becker JC, K\u00e4mpgen E, Br\u00f6cker E. Classical chemotherapy for metastatic melanoma. Clin. Exp. Dermatol. 2000;25(6):503-508.","journal-title":"Clin. Exp. Dermatol."},{"key":"5020_CR7","doi-asserted-by":"crossref","unstructured":"Collaborative Ocular Melanoma Study Group. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS). COMS report No. 15. Arch. Ophthalmol. 2001;119(5):670-676.","DOI":"10.1001\/archopht.119.5.670"},{"issue":"2","key":"5020_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","volume":"18","author":"S Landreville","year":"2012","unstructured":"Landreville S, Agapova OA, Matatall KA, Kneass ZT, Onken MD, Lee RS, Bowcock AM, Harbour JW. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin. Cancer Res. 2012;18(2):408-416.","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"5020_CR9","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1200\/JCO.1997.15.7.2589","volume":"15","author":"S Leyvraz","year":"1997","unstructured":"Leyvraz S, Spataro V, Bauer J, Pampallona S, Salmon R, Dorval T, Meuli R, Gillet M, Lejeune F, Zografos L. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J. Clin. Oncol. 1997;15(7):2589-2595.","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"5020_CR10","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1093\/carcin\/bgm091","volume":"28","author":"JC Marshall","year":"2007","unstructured":"Marshall JC, Fernandes BF, Di Cesare S, Maloney SC, Logan PT, Antecka E, Burnier MN Jr. The use of a cyclooxygenase-2 inhibitor (Nepafenac) in an ocular and metastatic animal model of uveal melanoma. Carcinogenesis. 2007;28(9):2053-2058.","journal-title":"Carcinogenesis."},{"issue":"11","key":"5020_CR11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1136\/bjo.80.11.1009","volume":"80","author":"M McNamara","year":"1996","unstructured":"McNamara M, Clynes M, Dunne B, NicAmhlaoibh R, Lee WR, Barnes C, Kennedy SM. Multidrug resistance in ocular melanoma. Br. J. Ophthalmol. 1996;80(11):1009-1012.","journal-title":"Br. J. Ophthalmol."},{"issue":"7","key":"5020_CR12","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.21873\/anticanres.12665","volume":"38","author":"MM Moschos","year":"2018","unstructured":"Moschos MM, Dettoraki M, Androudi S, Kalogeropoulos D, Lavaris A, Garmpis N, Damaskos C, Garmpi A, Tsatsos M. The role of histone deacetylase inhibitors in uveal melanoma: current evidence. Anticancer Res. 2018;38(7):3817-3824.","journal-title":"Anticancer Res."},{"issue":"8","key":"5020_CR13","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1080\/02713683.2017.1297997","volume":"42","author":"T Nayman","year":"2017","unstructured":"Nayman T, Bostan C, Logan P, Burnier MN Jr. Uveal melanoma risk factors: a systematic review of meta-analyses. Curr. Eye Res. 2017;42(8):1085-1093.","journal-title":"Curr. Eye Res."},{"issue":"9-10","key":"5020_CR14","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/sj.bjc.6690237","volume":"79","author":"MH Neale","year":"1999","unstructured":"Neale MH, Myatt N, Cree IA, Kurbacher CM, Foss AJ, Hungerford JL, Plowman PN. Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside. Br. J. Cancer. 1999;79(9-10):1487-1493.","journal-title":"Br. J. Cancer."},{"issue":"1","key":"5020_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s10517-018-4117-7","volume":"165","author":"SV Saakyan","year":"2018","unstructured":"Saakyan SV, Tsygankov \u0410Y, Moiseeva NI, Karamysheva \u0410F, Zhil\u2019tsova MG, Tadevosyan SS. Retinoblastoma cell culturing and evaluation of their drug resistance. Bull. Exp. Biol. Med. 2018;165(1):148-153.","journal-title":"Bull. Exp. Biol. Med."},{"issue":"2","key":"5020_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0748-7983(98)91485-8","volume":"24","author":"RJ Salmon","year":"1998","unstructured":"Salmon RJ, Levy C, Plancher C, Dorval T, Desjardins L, Leyvraz S, Pouillart P, Schlienger P, Servois V, Asselain B. Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur. J. Surg. Oncol. 1998;24(2):127-130.","journal-title":"Eur. J. Surg. Oncol."},{"issue":"12","key":"5020_CR17","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/annonc\/mdl309","volume":"17","author":"A Schmittel","year":"2006","unstructured":"Schmittel A, Schmidt-Hieber M, Martus P, Bechrakis NE, Schuster R, Siehl JM, Foerster MH, Thiel E, Keilholz U. A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma. Ann. Oncol. 2006;17(12):1826-1829.","journal-title":"Ann. Oncol."},{"issue":"8","key":"5020_CR18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/jamaophthalmol.2013.129","volume":"131","author":"CL Shields","year":"2013","unstructured":"Shields CL, Kaliki S, Livesey M, Walker B, Garoon R, Bucci M, Feinstein E, Pesch A, Gonzalez C, Lally SE, Mashayekhi A, Shields JA. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes. JAMA Ophthalmol. 2013;131(8):993-1003.","journal-title":"JAMA Ophthalmol."},{"issue":"9","key":"5020_CR19","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118(9):1881-1885.","journal-title":"Ophthalmology."},{"issue":"7","key":"5020_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00432-004-0569-4","volume":"130","author":"P Terheyden","year":"2004","unstructured":"Terheyden P, Br\u00f6cker EB, Becker JC. Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma. J. Cancer Res. Clin. Oncol. 2004;130(7):395-399.","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"5020_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00262-006-0185-z","volume":"56","author":"S Vertuani","year":"2007","unstructured":"Vertuani S, Dubrovska E, Levitsky V, Jager MJ, Kiessling R, Levitskaya J. Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells. Cancer Immunol. Immunother. 2007;56(2):193-204.","journal-title":"Cancer Immunol. Immunother."},{"issue":"12","key":"5020_CR22","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","volume":"114","author":"G Virgili","year":"2007","unstructured":"Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E; EUROCARE Working Group. Incidence of uveal melanoma in Europe. Ophthalmology. 2007;114(12):2309-2315.","journal-title":"Ophthalmology."},{"issue":"6","key":"5020_CR23","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.hoc.2012.08.004","volume":"26","author":"Y Yonekawa","year":"2012","unstructured":"Yonekawa Y, Kim IK. Epidemiology and management of uveal melanoma. Hematol. Oncol. Clin. North Am. 2012;26(6):1169-1184.","journal-title":"Hematol. Oncol. Clin. North Am."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-020-05020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10517-020-05020-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-020-05020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T22:54:36Z","timestamp":1606949676000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10517-020-05020-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5020"],"URL":"https:\/\/doi.org\/10.1007\/s10517-020-05020-3","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"15 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}